SEARCH

SEARCH BY CITATION

References

  • Ahnert-Hilger G., Brautigam M. and Gratzl M. (1987) Ca2+-stimulated catecholamine release from alpha-toxin-permeabilized PC12 cells: biochemical evidence for exocytosis and its modulation by protein kinase C and G proteins. Biochemistry 26, 78427848.
  • Beaulieu J. M., Sotnikova T. D., Yao W. D., Kockeritz L., Woodgett J. R., Gainetdinov R. R. and Caron M. G. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl Acad. Sci. USA 101, 50995104.
  • Bibb J. A., Chen J., Taylor J. R. et al. (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410, 376380.
  • Chen P. C. and Chen J. C. (2005) Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats. Neuropsychopharmacology 30, 538549.
  • Chergui K., Svenningsson P. and Greengard P. (2004) Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl Acad. Sci. USA 101, 21912196.
  • Chiang Y. C., Chen P. C. and Chen J. C. (2003) D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine. Brain Res. 972, 159167.
  • Courtney N. D., Howlett A. C. and Westfall T. C. (1991) Regulation of nicotine-evoked dopamine release from PC12 cells. Life Sci. 48, 16711678.
  • Cussac D., Newman-Tancredi A., Pasteau V. and Millan M. J. (1999) Human dopamine D(3) receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism. Mol. Pharmacol. 56, 10251030.
  • Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J. C. and Sokoloff P. (2000) Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J. Neurosci. 20, 86778684.
  • Fletcher A. I., Shuang R., Giovannucci D. R., Zhang L., Bittner M. A. and Stuenkel E. L. (1999) Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J. Biol. Chem. 274, 40274035.
  • Greengard P. (2001) The neurobiology of slow synaptic transmission. Science 294, 10241030.
  • Hernandez-Lopez S., Tkatch T., Perez-Garci E., Galarraga E., Bargas J., Hamm H. and Surmeier D. J. (2000) D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J. Neurosci. 20, 89878995.
  • Joseph J. D., Wang Y. M., Miles P. R., Budygin E. A., Picetti R., Gainetdinov R. R., Caron M. G. and Wightman R. M. (2002) Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 112, 3949.
  • Koeltzow T. E., Xu M., Cooper D. C., Hu X. T., Tonegawa S., Wolf M. E. and White F. J. (1998) Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J. Neurosci. 18, 22312238.
  • Kuzhikandathil E. V. and Oxford G. S. (1999) Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells. J. Neurosci. 19, 16981707.
  • Liu F., Ma X. H., Ule J., Bibb J. A., Nishi A., DeMaggio A. J., Yan Z., Nairn A. C. and Greengard P. (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA 98, 1106211068.
  • Mashhoon N., DeMaggio A. J., Tereshko V., Bergmeier S. C., Egli M., Hoekstra M. F. and Kuret J. (2000) Crystal structure of a conformation-selective casein kinase-1 inhibitor. J. Biol. Chem. 275, 2005220060.
  • Murthy K. S., Zhou H., Huang J. and Pentyala S. N. (2004) Activation of PLC-delta1 by Gi/o-coupled receptor agonists. Am. J. Physiol. Cell Physiol. 287, C1679C1687.
  • Pedrosa R., Gomes P., Hopfer U., Jose P. A. and Soares-da-Silva P. (2004) Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am. J. Physiol. Renal Physiol. 287, F1059F1066.
  • Richtand N. M., Woods S. C., Berger S. P. and Strakowski S. M. (2001) D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci. Biobehav. Rev. 25, 427443.
  • Robinson S. W. and Caron M. G. (1997) Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol. Pharmacol. 52, 508514.
  • Schmidt M., Lohmann B., Hammer K., Haupenthal S., Nehls M. V. and Jakobs K. H. (1998) Gi- and protein kinase C-mediated heterologous potentiation of phospholipase C signaling by G protein-coupled receptors. Mol. Pharmacol. 53, 11391148.
  • Sharma P., Sharma M., Amin N. D., Albers R. W. and Pant H. C. (1999) Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc. Natl Acad. Sci. USA 96, 1115611160.
  • Sokoloff P., Diaz J., Le Foll B., Guillin O., Leriche L., Bezard E. and Gross C. (2006) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol. Disord. Drug Targets 5, 2543.
  • Svenningsson P., Nishi A., Fisone G., Girault J.-A., Nairn A. C. and Greengard P. (2004) DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 44, 269296.
  • Tan T. C., Valova V. A., Malladi C. S. et al. (2003) Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol. 5, 701710.
  • Tang L., Todd R. D. and O’Malley K. L. (1994) Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270, 475479.
  • Tomizawa K., Ohta J., Matsushita M., Moriwaki A., Li S. T., Takei K. and Matsui H. (2002) Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22, 25902597.
  • Tomizawa K., Sunada S., Lu Y. F. et al. (2003) Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J. Cell Biol. 163, 813824.